Plant Comparison
Ivy Leaf vs Panax Ginseng
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Ivy Leaf and Panax Ginseng: both belong to the Araliaceae family.
Key Constituents
The secretolytic and antispasmodic active constituents; extracts are standardised to them.
The principal bioactive triterpene saponins of the root, considered responsible for most of ginseng's adaptogenic, neuroprotective and immunomodulatory activity; the ratio of protopanaxadiol- to protopanaxatriol-type ginsenosides differs between fresh, white and red ginseng.
Contribute to the immunomodulatory activity of the root.
Minor constituents contributing to the aroma and antioxidant activity.
Pharmacological Actions
Antispasmodic / bronchodilatory - eases coughing fits and breathlessness
Traditional & Indicated Uses
Expectorant / secretolytic for productive cough and acute bronchitis (loosens and helps clear mucus)
Expectorant / secretolytic for productive cough and acute bronchitis (loosens and helps clear mucus)
inferred from antispasmodic action
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from neuroprotective action
inferred from immunomodulator action
inferred from ergogenic action
inferred from anti-inflammatory action
inferred from ergogenic action
Safety, Cautions & Contraindications
Generally well tolerated; occasional gastrointestinal upset or, rarely, allergic reaction. Use only standardised extract products - the fresh raw plant contains irritant saponins and falcarinol that can cause contact dermatitis.
A cough lasting more than a week, or with fever, breathlessness or purulent sputum, needs medical assessment. Safety in pregnancy and breastfeeding is not established.
Generally well tolerated in short-term use (up to 3 months). May cause insomnia, headache, or gastrointestinal upset at high doses. Avoid during pregnancy and breastfeeding. May interact with warfarin, MAOIs, and diabetic medications. Not recommended for continuous use without breaks.
Duke (2002) rates Korean/Oriental ginseng (Panax ginseng) as highly active with clinical support for adaptogenic, immunostimulant, and performance-enhancing effects. Commission E approves standardized ginseng root extract (4–7% ginsenosides) as a tonic for fatigue and during convalescence. Dose: 200–600 mg standardized extract daily. Duke cautions about 'Ginseng Abuse Syndrome' (GAS) with overdose — symptoms include hypertension, insomnia, edema, and nervousness. Drug interactions are notable: ginseng potentiates MAOIs and may interact with warfarin, digoxin, and stimulants. Cycle use (2–3 weeks on, 2 weeks off) is recommended (Duke, 2002).
External Ids
Botanical Description
Woody, evergreen climbing or trailing vine that attaches to surfaces by small aerial rootlets. Juvenile leaves are glossy, dark green with three to five lobes; mature, flowering growth on well-lit stems produces unlobed, oval leaves. Small, greenish-yellow flowers in rounded umbels appear in autumn on mature growth, followed by black berries.[12]
Slow-growing perennial herb (Araliaceae), 30-60 cm tall, harvested at 4 years of age or older. A single erect stem bears a whorl of palmately compound leaves, each with 3-5 toothed leaflets, at its top. Small greenish-white flowers are borne in a single terminal umbel, followed by small red berries. The fleshy, often forked or human-shaped taproot - the origin of the name 'ginseng' ('renshen', man-root) - is the medicinal part.[3]
Habitat
Grows as a climbing or ground-covering evergreen on trees, walls, buildings and woodland floors, tolerant of shade; native to Europe and Western Asia and widely naturalised elsewhere.
Native to the cool-temperate deciduous mountain forests of Manchuria, Korea and the Russian Far East. Historically wild-harvested, it is now predominantly cultivated, mainly in Korea and China, under artificial shade for several years before harvest.[1]
Harvesting
Juvenile (lobed) leaves are picked for medicinal use, typically in spring to summer, then dried and processed into standardised extract; the fresh raw leaf is not used directly due to irritant saponins.
The root is harvested after at least 4-6 years of growth, once its ginsenoside content is fully developed. Roots are either air-dried as 'white ginseng' or steamed and then dried as 'red ginseng', a processing step that alters the ginsenoside profile.[3]
Traditional Uses
Ivy leaf has a long European folk history as an expectorant remedy for coughs and chest complaints, and modern standardised leaf extracts are among the best-studied herbal treatments for acute bronchitis and productive cough, shown in clinical trials to reduce cough severity and ease breathing.[12]
Ginseng is one of the most celebrated tonic herbs of East Asian traditional medicine, used for millennia as a general adaptogen to restore vitality, support recovery from illness and improve stamina and cognitive performance. Modern clinical research supports adaptogenic, immunomodulatory, antioxidant, neuroprotective and mild antidiabetic effects consistent with this traditional use.[1, 7]
Preparations
Leaf extract standardised to saponin (hederacoside C) content, formulated as a cough syrup or drops; the well-studied clinical form for acute bronchitis and productive cough.
Commission E-recognised standardised extract (4-7% ginsenosides), the most clinically studied preparation.
Traditional processed form (steamed then dried), which alters and concentrates the ginsenoside profile compared with white (unprocessed) ginseng.
Dosage
Commercial standardised ivy-leaf syrups are typically dosed per product labelling (varying by age); clinical trials show benefit within about 48 hours of starting treatment. Educational reference only, not a prescription.
References
Lookalikes Review
Drug Class Interactions
Not documented
Pairings
Not documented
Ginseng and feverfew both reduce blood clotting/platelet stickiness, so taking them together may add up and raise the risk of bruising or bleeding — use caution, especially before surgery or alongside blood-thinning drugs.[19, 20]
Ginseng and ginger both reduce blood clotting/platelet stickiness, so taking them together may add up and raise the risk of bruising or bleeding — use caution, especially before surgery or alongside blood-thinning drugs.[19, 21]
References & Sources
- Sierocinski, E., Holzinger, F. and Chenot, J.F (2021) 'Ivy leaf (Hedera helix) for acute upper respiratory tract infections: an updated systematic review', European Journal of Clinical Pharmacology, 77(8), pp. 1113-1122. doi:10.1007/s00228-021-03090-4 Meta-analysis / review
https://doi.org/10.1007/s00228-021-03090-4 - Baharara, H., Moghadam, A.T., Sahebkar, A., Emami, S.A. et al (2021) 'The Effects of Ivy (Hedera helix) on Respiratory Problems and Cough in Humans: A Review', Advances in Experimental Medicine and Biology, 1328, pp. 361-376. doi:10.1007/978-3-030-73234-9_23 Traditional / reference
https://doi.org/10.1007/978-3-030-73234-9_23 - Song, K.J., Shin, Y.J., Lee, K.R., Lee, E.J. et al (2015) 'Expectorant and antitussive effect of Hedera helix and Rhizoma coptidis extracts mixture', Yonsei Medical Journal, 56(3), pp. 819-824. doi:10.3349/ymj.2015.56.3.819 Preclinical
https://doi.org/10.3349/ymj.2015.56.3.819 - Yu, M., Liu, J., Li, L., Xu, H., Xing, Y., Zhao, Y. and Yu, Z (2016) 'Pharmacokinetic parameters of three active ingredients hederacoside C, hederacoside D, and alpha-hederin in Hedera helix in rats', Journal of Separation Science, 39(17), pp. 3292-3301. doi:10.1002/jssc.201600523 Preclinical
https://doi.org/10.1002/jssc.201600523 - Sieben, A., Prenner, L., Sorkalla, T., Wolf, A., Jakobs, D., Runkel, F. and Haberlein, H (2009) 'Alpha-hederin, but not hederacoside C and hederagenin from Hedera helix, affects the binding behavior, dynamics, and regulation of beta-2-adrenergic receptors', Biochemistry, 48(15), pp. 3477-3482. doi:10.1021/bi802036b Preclinical
https://doi.org/10.1021/bi802036b - Alkattan, A., Alameer, R., Alsalameen, E., Almaary, M., Alkhairat, M., Alkhalifah, A., Alghanim, F. and Radwan, N (2021) 'Safety of English ivy (Hedera helix) leaf extract during pregnancy: retrospective cohort study', DARU Journal of Pharmaceutical Sciences, 29(2), pp. 493-499. doi:10.1007/s40199-021-00415-7 Clinical study
https://doi.org/10.1007/s40199-021-00415-7 - Trute, A., Gross, J., Mutschler, E. and Nahrstedt, A (1997) 'In vitro antispasmodic compounds of the dry extract obtained from Hedera helix', Planta Medica, 63(2), pp. 125-129. doi:10.1055/s-2006-957627 Preclinical
https://doi.org/10.1055/s-2006-957627 - Gavrila, A.I., Tatia, R., Seciu-Grama, A., Tarcomnicu, I., Negrea, C., Calinescu, I., Zalaru, C., Moldovan, L., Raiciu, A.D. and Popa, I (2022) 'Ultrasound assisted extraction of saponins from Hedera helix L. and an in vitro biocompatibility evaluation of the extracts', Pharmaceuticals, 15(10), pp. 1197. doi:10.3390/ph15101197 Preclinical
https://doi.org/10.3390/ph15101197 - Suleyman, H., Mshvildadze, V., Gepdiremen, A. and Elias, R (2003) 'Acute and chronic antiinflammatory profile of the ivy plant, Hedera helix, in rats', Phytomedicine, 10(5), pp. 370-374. doi:10.1078/0944-7113-00260 Preclinical
https://doi.org/10.1078/0944-7113-00260 - Mendel, M., Chlopecka, M., Dziekan, N. and Wiechetek, M (2011) 'The effect of the whole extract of common ivy (Hedera helix) leaves and selected active substances on the motoric activity of rat isolated stomach strips', Journal of Ethnopharmacology, 134(3), pp. 796-802. doi:10.1016/j.jep.2011.01.036 Preclinical
https://doi.org/10.1016/j.jep.2011.01.036 - Rosca-Casian, O., Mircea, C., Vlase, L., Gheldiu, A., Teuca, D.T. and Parvu, M (2017) 'Chemical composition and antifungal activity of Hedera helix leaf ethanolic extract', Acta Biologica Hungarica, 68(2), pp. 196-207. doi:10.1556/018.68.2017.2.7 Preclinical
https://doi.org/10.1556/018.68.2017.2.7 - Kruttschnitt, E., Wegener, T., Zahner, C. and Henzen-Bucking, S (2020) 'Assessment of the Efficacy and Safety of Ivy Leaf Cough Syrup Compared with Acetylcysteine in Adults and Children with Acute Bronchitis', Evidence-Based Complementary and Alternative Medicine. doi:10.1155/2020/1910656 Clinical study
https://doi.org/10.1155/2020/1910656 - Schonknecht, K., Fal, A.M., Mastalerz-Migas, A., Joachimiak, M. and Doniec, Z (2017) 'Efficacy of dry extract of ivy leaves in the treatment of productive cough', Wiadomosci Lekarskie. Randomized trial
https://scholar.google.com/scholar?q=Efficacy%20of%20dry%20extract%20of%20ivy%20leaves%20in%20the%20treatment%20of%20productive%20cough - Schaefer, A., Kehr, M.S., Giannetti, B.M., Bulitta, M. and Staiger, C (2016) 'A randomized, controlled, double-blind, multi-center trial to evaluate the efficacy and safety of a liquid containing ivy leaves dry extract (EA 575) vs. placebo in the treatment of adults with acute cough', Die Pharmazie, 71(9), pp. 504--509. doi:10.1691/ph.2016.6712 Randomized trial
https://doi.org/10.1691/ph.2016.6712
- Mancuso, C. and Santangelo, R (2017) 'Panax ginseng and Panax quinquefolius: From pharmacology to toxicology', Food and Chemical Toxicology, 107(Pt A), pp. 362-372. doi:10.1016/j.fct.2017.07.019 Meta-analysis / review
https://doi.org/10.1016/j.fct.2017.07.019 - Zhou, Z., Li, M., Zhang, Z., Song, Z. and others (2024) 'Overview of Panax ginseng and its active ingredients protective mechanism on cardiovascular diseases', Journal of Ethnopharmacology, 334, pp. 118506. doi:10.1016/j.jep.2024.118506 Meta-analysis / review
https://doi.org/10.1016/j.jep.2024.118506 - Liu, H., Lu, X., Hu, Y. and Fan, X (2020) 'Chemical constituents of Panax ginseng and Panax notoginseng explain why they differ in therapeutic efficacy', Pharmacological Research, 161, pp. 105263. doi:10.1016/j.phrs.2020.105263 Meta-analysis / review
https://doi.org/10.1016/j.phrs.2020.105263 - Fan, S., Zhang, Z., Su, H., Xu, P. and others (2020) 'Panax ginseng clinical trials: Current status and future perspectives', Biomedicine & Pharmacotherapy, 132, pp. 110832. doi:10.1016/j.biopha.2020.110832 Meta-analysis / review
https://doi.org/10.1016/j.biopha.2020.110832 - Ni, X.C., Wang, H.F., Cai, Y.Y., Yang, D. and others (2022) 'Ginsenoside Rb1 inhibits astrocyte activation and promotes transfer of astrocytic mitochondria to neurons against ischemic stroke', Redox Biology, 54, pp. 102363. doi:10.1016/j.redox.2022.102363 Preclinical
https://doi.org/10.1016/j.redox.2022.102363 - Arring, N.M., Millstine, D., Marks, L.A. and Nail, L.M (2018) 'Ginseng as a Treatment for Fatigue: A Systematic Review', Journal of Alternative and Complementary Medicine, 24(7), pp. 624-633. doi:10.1089/acm.2017.0361 Meta-analysis / review
https://doi.org/10.1089/acm.2017.0361 - Zhou, G., Wang, C.Z., Mohammadi, S., Sawadogo, W.R. and others (2023) 'Pharmacological Effects of Ginseng: Multiple Constituents and Multiple Actions on Humans', The American Journal of Chinese Medicine, 51(5), pp. 1085-1104. doi:10.1142/S0192415X23500507 Meta-analysis / review
https://doi.org/10.1142/S0192415X23500507 - Ramanathan, M.R. and Penzak, S.R (2017) 'Pharmacokinetic Drug Interactions with Panax ginseng', European Journal of Drug Metabolism and Pharmacokinetics, 42(4), pp. 545-557. doi:10.1007/s13318-016-0387-5 Meta-analysis / review
https://doi.org/10.1007/s13318-016-0387-5 - Li, J., Huang, Q., Chen, J., Qi, H. and others (2021) 'Neuroprotective Potentials of Panax Ginseng Against Alzheimer's Disease: A Review of Preclinical and Clinical Evidences', Frontiers in Pharmacology, 12, pp. 688490. doi:10.3389/fphar.2021.688490 Meta-analysis / review
https://doi.org/10.3389/fphar.2021.688490 - Geng, J., Dong, J., Ni, H., Lee, M.S. and others (2010) 'Ginseng for cognition', Cochrane Database of Systematic Reviews, (12), pp. CD007769. doi:10.1002/14651858.CD007769.pub2 Meta-analysis / review
https://doi.org/10.1002/14651858.CD007769.pub2 - Attele, A.S., Wu, J.A. and Yuan, C.S (1999) 'Ginseng pharmacology: multiple constituents and multiple actions', 58(11), pp. 1685--1693. doi:10.1016/s0006-2952(99)00212-9 Traditional / reference
https://doi.org/10.1016/s0006-2952(99)00212-9 - Kiefer, D. and Pantuso, T (2003) 'Panax ginseng', 68(8), pp. 1539--1542. Traditional / reference
https://scholar.google.com/scholar?q=Panax%20ginseng - Park, H.J., Kim, D.H. and Park, S.J (2014) 'Ginseng in traditional herbal prescriptions', 38(1), pp. 1--7. doi:10.5142/jgr.2012.36.3.225 Randomized trial
https://doi.org/10.5142/jgr.2012.36.3.225 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Izzo, A.A. and Ernst, E (2009) 'Interactions between herbal medicines and prescribed drugs: an updated systematic review', Drugs, 69(13), pp. 1777-1798. doi:10.2165/11317010-000000000-00000 Meta-analysis / review
https://doi.org/10.2165/11317010-000000000-00000 - Yuan, C.S., Wei, G., Dey, L., Karrison, T., Nahlik, L., Maleckar, S., Kasza, K., Ang-Lee, M. and Moss, J (2004) 'American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled trial', Annals of Internal Medicine, 141(1), pp. 23-27. doi:10.7326/0003-4819-141-1-200407060-00011 Randomized trial
https://doi.org/10.7326/0003-4819-141-1-200407060-00011 - Sotaniemi, E.A., Haapakoski, E. and Rautio, A (1995) 'Ginseng therapy in non-insulin-dependent diabetic patients', Diabetes Care, 18(10), pp. 1373-1375. doi:10.2337/diacare.18.10.1373 Randomized trial
https://doi.org/10.2337/diacare.18.10.1373 - Vuksan, V., Sievenpiper, J.L., Koo, V.Y., Francis, T., Beljan-Zdravkovic, U., Xu, Z. and Vidgen, E (2000) 'American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus', Archives of Internal Medicine, 160(7), pp. 1009-1013. doi:10.1001/archinte.160.7.1009 Randomized trial
https://doi.org/10.1001/archinte.160.7.1009 - Ang-Lee, M.K., Moss, J. and Yuan, C.S (2001) 'Herbal medicines and perioperative care', JAMA, 286(2), pp. 208-216. doi:10.1001/jama.286.2.208 Meta-analysis / review
https://doi.org/10.1001/jama.286.2.208 - Groenewegen, W.A. and Heptinstall, S (1990) 'A comparison of the effects of an extract of feverfew and parthenolide, a component of feverfew, on human platelet activity in-vitro', Journal of Pharmacy and Pharmacology, 42(8), pp. 553-557. doi:10.1111/j.2042-7158.1990.tb07057.x Preclinical
https://doi.org/10.1111/j.2042-7158.1990.tb07057.x - Jiang, X., Williams, K.M., Liauw, W.S., Ammit, A.J., Roufogalis, B.D., Duke, C.C., Day, R.O. and McLachlan, A.J (2005) 'Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects', British Journal of Clinical Pharmacology, 59(4), pp. 425-432. doi:10.1111/j.1365-2125.2005.02322.x Randomized trial
https://doi.org/10.1111/j.1365-2125.2005.02322.x
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.